Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In patients who have had type 1 diabetes for 5 years, current recommendations regarding screening for diabetic retinopathy include annual dilated retinal examinations to detect proliferative retinopathy or clinically significant macular edema, both of which require timely intervention to preserve vision. During 30 years of the Diabetes Control and Complications Trial (DCCT) and its longitudinal follow-up Epidemiology of Diabetes Interventions and Complications (EDIC) study, retinal photography was performed at intervals of 6 months to 4 years. METHODS: We used retinal photographs from the DCCT/EDIC study to develop a rational screening frequency for retinopathy. Markov modeling was used to determine the likelihood of progression to proliferative diabetic retinopathy or clinically significant macular edema in patients with various initial retinopathy levels (no retinopathy or mild, moderate, or severe nonproliferative diabetic retinopathy). The models included recognized risk factors for progression of retinopathy. RESULTS: Overall, the probability of progression to proliferative diabetic retinopathy or clinically significant macular edema was limited to approximately 5% between retinal screening examinations at 4 years among patients who had no retinopathy, 3 years among those with mild retinopathy, 6 months among those with moderate retinopathy, and 3 months among those with severe nonproliferative diabetic retinopathy. The risk of progression was also closely related to mean glycated hemoglobin levels. The risk of progression from no retinopathy to proliferative diabetic retinopathy or clinically significant macular edema was 1.0% over 5 years among patients with a glycated hemoglobin level of 6%, as compared with 4.3% over 3 years among patients with a glycated hemoglobin level of 10%. Over a 20-year period, the frequency of eye examinations was 58% lower with our practical, evidence-based schedule than with routine annual examinations, which resulted in substantial cost savings. CONCLUSIONS: Our model for establishing an individualized schedule for retinopathy screening on the basis of the patient's current state of retinopathy and glycated hemoglobin level reduced the frequency of eye examinations without delaying the diagnosis of clinically significant disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; DCCT/EDIC ClinicalTrials.gov numbers, NCT00360893 and NCT00360815 .).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonhealing ulcers and bacterial infections increase the rate of progression of retinopathy,496,498”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [498]
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationTurner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
(2007) · Developments in Ophthalmology · doi:10.1159/isbn.978-3-318-01439-6 · Cited by 5,583
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
The Theory of Stochastic Processes
Cox, D. R., Miller, H. D., Weiss, G., & Shuler, K. (1966) · Physics Today · doi:10.1063/1.3047872 · Cited by 3,324
(1985) · Archives of Ophthalmology · doi:10.1001/archopht.1985.01050120030015 · Cited by 2,540
Antonetti, D. A., Klein, R., & Gardner, T. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1005073 · Cited by 1,659
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss
Lee, R., Wong, T. Y., & Sabanayagam, C. (2015) · Eye and Vision · doi:10.1186/s40662-015-0026-2 · Cited by 1,569
Research works printed but not linked: 1
- Wang JK, 2015, Eye Sci, 30, 176
Cited by
Chiang, J. L., Maahs, D. M., Garvey, K. C., Hood, K. K., Laffel, L. M., Weinzimer, S. A., Wolfsdorf, J. I., & Schatz, D. (2018) · Diabetes Care · doi:10.2337/dci18-0023 · Cited by 509
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Incidence and progression of diabetic retinopathy: a systematic review
Sabanayagam, C., Banu, R., Chee, M. L., Lee, R., Wang, Y. X., Tan, G., Jonas, J. B., Lamoureux, E. L., Cheng, C.-Y., Klein, B. E. K., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30128-1 · Cited by 491
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s011 · Cited by 460
Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy
Lin, K., Hsih, W., Lin, Y., Wen, C., & Chang, T. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13480 · Cited by 446
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 398
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395
14. Children and Adolescents: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s014 · Cited by 367
10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 302
13. Children and Adolescents: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s013 · Cited by 267
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gibbons, C. H., Giurini, J. M., Hilliard, M. E., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s012 · Cited by 207
“…was little risk of development of signi fi cant retinopathy within a 3-year interval after a normal examination (13), and less frequent intervals have been found in simulated modeling to be potentially effective in screening for diabetic retinopathy in individuals without diabetic retinopathy (14).”
Influential13. Children and Adolescents: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s013 · Cited by 223
14. Children and Adolescents: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s014 · Cited by 200
14. Children and Adolescents: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s014 · Cited by 165
12. Retinopathy, Neuropathy, and Foot Care: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s012 · Cited by 177
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Callaghan, B. C., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s012 · Cited by 176
14. Children and Adolescents: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s014 · Cited by 173
Code-free deep learning for multi-modality medical image classification
Korot, E., Guan, Z., Ferraz, D., Wagner, S. K., Zhang, G., Liu, X., Faes, L., Pontikos, N., Finlayson, S. G., Khalid, H., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-021-00305-2 · Cited by 171
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gibbons, C. H., Giurini, J. M., Hilliard, M. E., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s012 · Cited by 169
Bjornstad, P., Dart, A. B., Donaghue, K. C., Dost, A., Feldman, E. L., Tan, G. S. W., Wadwa, R. P., Zabeen, B., & Marcovecchio, M. L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13444 · Cited by 196
“The prevalence of kidney failure is fortunately relatively rare in T1D.63 In a Finnish cohort, the cumulative risk of kidney failure was 2.2% after 20 years and 7.0% after 30 years diabetes duration.”
MethodInfluentialVision-Related Functional Burden of Diabetic Retinopathy Across Severity Levels in the United States
Willis, J. R., Doan, Q. V., Gleeson, M. L., Hašková, Z., Ramulu, P. Y., Morse, L. S., & Cantrell, R. A. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2553 · Cited by 150
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Callaghan, B. C., ChallaSivaKanaka, S., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s012 · Cited by 220
Diabetic retinopathy screening in the emerging era of artificial intelligence
Grauslund, J. (2022) · Diabetologia · doi:10.1007/s00125-022-05727-0 · Cited by 146
Early Detection of CKD: Implications for Low-Income, Middle-Income, and High-Income Countries
Tonelli, M. A., & Dickinson, J. A. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030277 · Cited by 136
Detection of Diabetic Retinopathy in Retinal Fundus Images Using CNN Classification Models
Asia, A.-O., Zhu, C., Althubiti, S. A., AL-Alimi, D., Xiao, Y., Ouyang, P., & Al‐qaness, M. A. A. (2022) · Electronics · doi:10.3390/electronics11172740 · Cited by 132
“…challenging the provision of specialized eye care for everyone, thereby imposing a huge labor-intensive burden on medical experts and costs for medical services; these issues and the growing waiting list for ophthalmic consultations are the main problems facing public health systems [5–7].”
Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China
Huang, X.-M., Yang, B.-F., Zheng, W.-L., Liu, Q., Xiao, F., Ouyang, P.-W., Li, M.-J., Li, X.-Y., Meng, J., Zhang, T.-T., et al. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07655-6 · Cited by 89
Ting, D. S. W., Cheung, C. Y., Nguyen, Q., Sabanayagam, C., Lim, G., Lim, Z. W., Tan, G. S. W., Soh, Y. Q., Schmetterer, L., Wang, Y. X., et al. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0097-x · Cited by 82
Evidence‐based Danish guidelines for screening of diabetic retinopathy
Grauslund, J., Andersen, N., Andresen, J., Flesner, P., Haamann, P., Heegaard, S., Larsen, M., Laugesen, C. S., Schielke, K. C., Skov, J., et al. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13936 · Cited by 82
“…Epidemiology of Diabetes Interventions and Complications Study (EDIC), it was demonstrated that the screening interval that led to a 5%-risk of progression to PDR or CSMO would be 4 years (no DR), 3 years (mild NPDR), 6 months (moderate NPDR) and 3 months (severe NPDR), respectively (DCCT 2017).”
BackgroundMoon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Understanding inherent image features in CNN-based assessment of diabetic retinopathy
Reguant, R., Brunak, S., & Saha, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89225-0 · Cited by 87
Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy
Fiori, A., Terlizzi, V., Kremer, H., Gebauer, J. E., Hammes, H., Harmsen, M. C., & Bieback, K. (2018) · Immunobiology · doi:10.1016/j.imbio.2018.01.001 · Cited by 72
14. Children and Adolescents: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s014 · Cited by 101
Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., McKnight, J. M., Green, F., Collier, A., McKeigue, P. M., & Colhoun, H. M. (2020) · Diabetes Care · doi:10.2337/dc19-1582 · Cited by 59
Xie, Y., Gunasekeran, D. V., Balaskas, K., Keane, P. A., Sim, D. A., Bachmann, L. M., Macrae, C., & Ting, D. S. W. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.2.22 · Cited by 59
Melo, L. G. N., Morales, P. H., Drummond, K. R. G., Santos, D. C., Pizarro, M., Barros, B. S. V., Mattos, T. C. L., Pinheiro, A. A., Mallmann, F., Leal, F. S. L., et al. (2018) · BMC Public Health · doi:10.1186/s12889-018-5859-x · Cited by 61
“However, recent studies have shown a tendency towards individualized retinal screening intervals based on glycated hemoglobin levels, type and the duration of diabetes [8].”
Molitch, M. E., Gao, X., Bebu, I., de Boer, I. H., Lachin, J. M., Paterson, A. D., Perkins, B. A., Saenger, A. K., Steffes, M. W., & Zinman, B. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14831218 · Cited by 52
Integration of genomics and transcriptomics predicts diabetic retinopathy susceptibility genes
Skol, A. D., Jung, S. C., Sokovic, A. M., Chen, S., Fazal, S., Sosina, O. A., Borkar, P. P., Lin, A., Sverdlov, M. S., Cao, D., et al. (2020) · eLife · doi:10.7554/elife.59980 · Cited by 56
Vascular Complication in Adolescents With Diabetes Mellitus
Graves, L. E., & Donaghue, K. C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00370 · Cited by 56
High remnant cholesterol level is relevant to diabetic retinopathy in type 2 diabetes mellitus
Shan, Y., Wang, Q., Zhang, Y., Tong, X., Pu, S., Xu, Y., & Gao, X. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-021-01621-7 · Cited by 48
“Although the relationship between HbA1c and DR is widely recognised [37, 38], the current study found no significant difference in HbA1c between the DR group and the non-DR participants [8.”
Silva, P. S., Zhang, D., Jacoba, C. M. P., Fickweiler, W., Lewis, D., Leitmeyer, J., Curran, K., Salongcay, R. P., Doan, D., Ashraf, M., et al. (2024) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2023.6318 · Cited by 49
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 85
Diabetic Eye Screening: Knowledge and Perspectives from Providers and Patients
Liu, Y., & Swearingen, R. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0911-2 · Cited by 48
Yoshizumi, H., Ejima, T., Nagao, T., & Wakisaka, M. (2018) · American Journal of Case Reports · doi:10.12659/ajcr.909708 · Cited by 40
Diabetic Retinopathy –Incidence And Risk Factors In A Community Setting- A Longitudinal Study
Shani, M., Eviatar, T., Komaneshter, D., & Vinker, S. (2018) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813432.2018.1487524 · Cited by 31
García‐Fiñana, M., Hughes, D. M., Cheyne, C. P., Broadbent, D., Wang, A., Komárek, A., STRATTON, I. M., Mobayen‐Rahni, M., Alshukri, A., Vora, J. P., et al. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13552 · Cited by 36
Multistate models for the natural history of cancer progression
Cheung, L. C., Albert, P. S., Das, S., & Cook, R. J. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01904-5 · Cited by 38
Hainsworth, D. P., Gangula, A., Ghoshdastidar, S., Kannan, R., & Upendran, A. (2020) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2020.01.032 · Cited by 29
Li, H., Li, G., Li, N., Liu, C., Yuan, Z., Gao, Q., Hao, S., Fan, S., & Yang, J. (2023) · PLOS ONE · doi:10.1371/journal.pone.0291390 · Cited by 27
Prevalence of diabetic retinopathy in children and adolescents at an urban tertiary eye care center
Porter, M., Channa, R., Wagner, J., Prichett, L. M., Liu, T. Y. A., & Wolf, R. M. (2020) · Pediatric Diabetes · doi:10.1111/pedi.13037 · Cited by 31
Branched-Chain Amino Acids Metabolism and Their Roles in Retinopathy: From Relevance to Mechanism
Zhang, X., Xia, M., Wu, Y., & Zhang, F. (2023) · Nutrients · doi:10.3390/nu15092161 · Cited by 30
“Retinopathy, as one of the leading diseases causing visual impairment and blindness, includes diabetic retinopathy (DR), age-related macular degeneration (AMD), and many other retinal diseases [2,3].”
BackgroundScreening for Diabetic Retinopathy
Rosenberg, J. B., & Tsui, I. (2017) · New England Journal of Medicine · doi:10.1056/nejme1701820 · Cited by 29
Kang, E. Y., Lo, F., Wang, J., Yeh, L., Wu, A., Tseng, Y.-J., Yeh, C.-T., Liu, L., Chen, K., Wu, W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30521-7 · Cited by 26
Bebu, I., Braffett, B. H., de Boer, I. H., Aiello, L. P., Bantle, J. P., Lorenzi, G. M., Herman, W. H., Gubitosi‐Klug, R., Perkins, B. A., Lachin, J. M., et al. (2022) · Diabetes Care · doi:10.2337/dc22-1744 · Cited by 29
Chen, Y.-J., Khouri, A. S., Zarbin, M. A., & Szirth, B. C. (2020) · Retina · doi:10.1097/iae.0000000000003047 · Cited by 23
Screening eye exams in youth with type 1 diabetes under 18 years of age: Once may be enough?
Gubitosi‐Klug, R., Bebu, I., White, N. H., Malone, J. I., Miller, R., Lorenzi, G. M., Hainsworth, D. P., Trapani, V. R., Lachin, J. M., & Tamborlane, W. V. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12877 · Cited by 25
Braffett, B. H., Bebu, I., Lorenzi, G. M., Martin, C. L., Perkins, B. A., Gubitosi‐Klug, R., & Nathan, D. M. (2025) · Diabetes Care · doi:10.2337/dc24-2885 · Cited by 28
Londero, T. M., Giaretta, L. S., Farenzena, L. P., Manfro, R. C., Canani, L. H. S., Lavinsky, D., Leitão, C. B., & Bauer, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01521 · Cited by 22
Ochs, A., McGurnaghan, S. J., Black, M. W., Leese, G., Philip, S., Sattar, N. A., Styles, C., Wild, S. H., McKeigue, P., & Colhoun, H. M. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002945 · Cited by 23
Liu, D., Haq, Z., Yang, D., & Stewart, J. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0253928 · Cited by 21
Benitez‐Aguirre, P., Marcovecchio, M. L., Chiesa, S. T., Craig, M. E., Wong, T. Y., Davis, E. A., Cotterill, A. M., Couper, J., Cameron, F. J., Mahmud, F. H., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05661-1 · Cited by 21
Validation of a model for the prediction of retinopathy in persons with type 1 diabetes
Schreur, V., Ng, H., Nijpels, G., Stefánsson, E., Tack, C. J., Klevering, B. J., de Jong, E. K., Hoyng, C. B., KEUNEN, J. E. E., & van der Heijden, A. A. W. A. (2019) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2018-313539 · Cited by 21
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 26
“66 • Рекомендуется срочно направлять на консультацию к врачу-офтальмологу – специалисту по ДР пациентов с СД 1 при наличии признаков ДМО, препролиферативной или пролиферативной ДР для дополнительного обследования и своевременного лечения [31, 195].”
A Clinical Decision Support System to Stratify the Temporal Risk of Diabetic Retinopathy
Bernardini, M., Romeo, L., Mancini, A., & Frontoni, E. (2021) · IEEE Access · doi:10.1109/access.2021.3127274 · Cited by 23
“…diabetic patients’ fundus images were analysed to simplify individualized risk assessments: an accurate assessment of the risk of proliferative DR or clinically significant macular edema was possible with the use of only the patient’s current retinopathy status and glycated hemoglobin levels [12].”
BackgroundMethodThomas, R., Winfield, T. G., Prettyjohns, M., Dunstan, F., Cheung, W., Anderson, P. M., Peter, R., Luzio, S. D., & Owens, D. R. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01191-y · Cited by 18
Chamard, C., Daïen, V., Erginay, A., Gautier, J., Villain, M., Tadayoni, R., Carrière, I., & Massin, P. (2020) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2020-316030 · Cited by 18
Bratina, N., Auzanneau, M., Birkebæk, N., de Beaufort, C. E., Cherubini, V., Craig, M. E., Dabelea, D., Dovč, K., Hofer, S. E., Holl, R. W., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13416 · Cited by 17
Transition probabilities of diabetic retinopathy and death in an Asian population with diabetes
Seshasai, S., He, F., Lam, B., Hamzah, H., Cheng, C., Li, J., Wong, T. Y., Tan, G. S. W., & Sabanayagam, C. (2024) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2024.100070 · Cited by 17
Dweib, M., & Sharif, N. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12216719 · Cited by 18
“The adherence to evidence-based methods underscores the significance of proactive monitoring and comprehensive documentation in the optimization of retinopathy therapy, thereby mitigating the risk of blindness associated with this condition [95–97].”
MethodSurowiec, P., Matejko, B., Kopka, M., Filemonowicz-Skoczek, A., Klupa, T., Cyganek, K., Romanowska‐Dixon, B., & Malecki, M. T. (2021) · Endocrine · doi:10.1007/s12020-021-02871-2 · Cited by 13
Januszewski, A. S., Velayutham, V., Benitez‐Aguirre, P., Craig, M. E., Cusumano, J. M., Pryke, A., Hing, S. J., Liew, G., Cho, Y. H., Chew, E. Y., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0071 · Cited by 11
Melo, L. G. N., Morales, P. H., Drummond, K. R. G., Santos, D. C., Pizarro, M., Barros, B. S. V., Mattos, T. C. L., Pinheiro, A. A., Mallmann, F., Leal, F. S. L., et al. (2018) · Acta Ophthalmologica · doi:10.1111/aos.13760 · Cited by 10
Chawla, R., Kumar, S., Kumawat, D., Azad, S. V., Temkar, S., & Jain, S. (2019) · European Journal of Ophthalmology · doi:10.1177/1120672119875341 · Cited by 10
Rêgo, S., Monteiro‐Soares, M., Dutra-Medeiros, M., Soares, F., Dias, C. C., & Nunes, F. (2022) · Diabetology · doi:10.3390/diabetology3010001 · Cited by 10
Grauslund, J., Stokholm, L., Thykjær, A. S., Möller, S., Laugesen, C. S., Andresen, J., Bek, T., la Cour, M., Heegaard, S., Højlund, K., et al. (2021) · Ophthalmology Science · doi:10.1016/j.xops.2021.100011 · Cited by 11
Manejo da retinopatia diabética
Malerbi, F. K., Andrade, R., Morales, P. H., Alves, S. T. D. F., Rodacki, M., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-17 · Cited by 12
Zhang, L., Zhao, H., & Chen, B. (2019) · International Journal of Ophthalmology · doi:10.18240/ijo.2019.07.03 · Cited by 10
Feasibility of large experimental animal models in testing novel therapeutic strategies for diabetes
Nagaya, M., Hasegawa, K., Uchikura, A., Nakano, K., Watanabe, M., Umeyama, K., Matsunari, H., Osafune, K., Kobayashi, E., Nakauchi, H., et al. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.306 · Cited by 7
Optimal Frequency of Urinary Albumin Screening in Type 1 Diabetes
Perkins, B. A., Bebu, I., de Boer, I. H., Molitch, M. E., Zinman, B., Bantle, J. P., Lorenzi, G. M., Nathan, D. M., & Lachin, J. M. (2022) · Diabetes Care · doi:10.2337/dc22-1420 · Cited by 8
Wroblewski, J. J., McChancy, C., Pickel, K., Buterbaugh, H., Wieland, T., & Gonzalez-Vazquez, A. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819882719 · Cited by 7
Frequency of Evidence-Based Screening for Diabetic Retinopathy
Lamoureux, E. L., Taylor, H., & Wong, T. Y. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1706322 · Cited by 7
Measuring Outcomes of Diabetic Retinopathy Screening: What Is Important?
Donaghue, K. C., & Liew, G. (2024) · Diabetes Care · doi:10.2337/dci24-0021 · Cited by 6
Diabetic Retinopathy: A Pharmacological Consideration
Maheshwari, S. Y., Kumar, S. K., Sinha, A. H., & Kumar, M. (2023) · Cureus · doi:10.7759/cureus.46842 · Cited by 6
Thomas, R., & Ng, S. M. (2020) · Journal of Diabetes and Clinical Research · doi:10.33696/diabetes.1.021 · Cited by 8
Sugawa, S. W., Yoshida, Y., Hikima, Y., Sato, H., Shimada, A., Noda, M., & Kushiyama, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/7572326 · Cited by 5
“Frequent follow-up is required in high-risk groups with more advanced DR and high HbA1c levels [38].”
BackgroundManagement of Diabetes Mellitus
Jenkins, A. J., SCOTT, E. S., Fulcher, J., Kilov, G., & Januszewski, A. S. (2018) · Contemporary cardiology · doi:10.1007/978-3-319-97622-8_7 · Cited by 6
Prevalence and Risk Factors of Diabetic Macular Edema in Type 1 Diabetes
Marques-Couto, P., Afonso, J., Coelho-Costa, I., Neves, J. S., Falcão, M. S., & Laiginhas, R. (2025) · Ophthalmology Retina · doi:10.1016/j.oret.2025.09.008 · Cited by 6
The Danish Ophthalmological Society guidelines for screening of diabetic retinopathy
Grauslund, J., Andersen, N., Andresen, J. L., Bek, T., Knudsen, S. T., & Subhi, Y. (2025) · AJO International · doi:10.1016/j.ajoint.2025.100141 · Cited by 4
Is sex an influential factor in type‐1 diabetes neurofunctional development? A preliminary study
González‐Garrido, A. A., Gallardo‐Moreno, G. B., Romo‐Vázquez, R., Vélez-Pérez, H. A., Farias, A. F.-S., Mendizabal‐Ruiz, G., Santos, S. R., Ruiz‐Stovel, V. D., Gómez-Velázquez, F. R., & Ramos‐Loyo, J. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24268 · Cited by 4
Junior, P. P. D. O., & de Castro, F. A. G. (2022) · Revista Brasileira de Medicina de Família e Comunidade · doi:10.5712/rbmfc17(44)3239 · Cited by 7
Sight‐threatening retinopathy in nine adolescents with early onset type 1 diabetes
Graves, L. E., Pryke, A., Cho, Y. H., Cusumano, J. M., Craig, M. E., Liew, G., & Donaghue, K. C. (2021) · Pediatric Diabetes · doi:10.1111/pedi.13265 · Cited by 3
Fujita, Y., & Haneda, M. (2021) · Diabetology International · doi:10.1007/s13340-021-00559-6 · Cited by 3
Quinn, N. B., Yang, F., Ryan, C. J., Bursell, S., KEECH, A. C., Atkinson‐Briggs, S., Jenkins, A. J., & Brazionis, L. (2020) · Internal Medicine Journal · doi:10.1111/imj.14971 · Cited by 3
Bek, T., Andersen, N., Andresen, J. L., Grauslund, J., Hajari, J. N., Laugesen, C. S., Schielke, K. C., & Petersen, L. (2024) · Acta Ophthalmologica · doi:10.1111/aos.16637 · Cited by 3
Novel strategy for screening of diabetic retinopathy
Takagi, H. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12770 · Cited by 3
Screening for Diabetic Retinopathy – a Twelve-Month Review
Gračner, T. (2020) · Acta Clinica Croatica · doi:10.20471/acc.2020.59.03.05 · Cited by 4
Chew, E. Y. (2023) · Diabetes Care · doi:10.2337/dci22-0062 · Cited by 2
Lian, J., So, C., McGhee, S. M., Thach, T., Lam, C. L. K., Fung, C. S. C., Kwong, A. S. K., & Chan, J. C. H. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0142 · Cited by 2
Weng, J., Guo, R., Liu, D., Huang, S., & Weng, S. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.111122 · Cited by 3
Salas, A. M., Benton, R. A., McLaughlin, A. C., Grace, L. R., Mayorga, M. E., González, J. M., & FRANSEN, S. R. (2022) · Proceedings of the Human Factors and Ergonomics Society Annual Meeting · doi:10.1177/1071181322661109 · Cited by 2
Vulnerabilities in diabetic eye screening for children and young people in England
Ibanez-Bruron, M. C., Solebo, A. L., Cumberland, P. M., Rahi, J. S., on behalf of the Diabetic Eye Disease in Childhood Study (DECS) group, Althauser, S., Anderson, J., Ashworth, J. L., Ayoola, O., Bhattacharyya, P., et al. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12887 · Cited by 2
Metadata
- Authors
- The DCCT/EDIC Research Group
- Affiliations
- Harvard University (US)
- Corresponding author
- The DCCT/EDIC Research Group
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-04-20
- Volume
- 376
- Issue
- 16
- Pages
- 1507-1516
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC5557280
- OpenAlex
- W2612354450
- Cited by
- 141
- References
- 35
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 11 · 2023: 15 · 2022: 20 · 2021: 14 · 2020: 20 · 2019: 14 · 2018: 18 · 2017: 8
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5u01dk094157-13, UL1TR001863)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK036836, P30DK017047)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- diabetic retinopathy, type 1 diabetes, proliferative diabetic retinopathy, clinically significant macular edema, fundus photography, HbA1c, retinopathy progression, Markov model, cost reduction, DCCT/EDIC
- MeSH terms
- Adolescent, Adult, Diabetes Mellitus, Type 1, Diabetic Retinopathy, Follow-Up Studies, Glycated Hemoglobin, Humans, Macular Edema, Markov Chains, Photography, Retina, Risk Factors, Visual Acuity, Practice Guidelines as Topic, Disease Progression, Evidence-Based Medicine, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.